NASDAQ:APVO

Aptevo Therapeutics Stock Insider Trading

etoro logo Buy APVO
*Your capital is at risk
$4.11
-0.0200 (-0.484%)
At Close: Jul 31, 2026

Aptevo Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 303.01K and sold 0 APVO shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
100.00
Buy 303.01K shares
Sell 0 shares
100% Buy Activity
Weak Negative Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Jul 17, 2025
Buy
Common Stock
M-Exempt
Kwon Soyoung
SVP, GC, Bd & Corp Affairs
Officer 3
Value: $0
Jul 17, 2025
Buy
Restricted Stock Unit
M-Exempt
Kwon Soyoung
SVP, GC, Bd & Corp Affairs
Officer 3
Value: $9
Jul 17, 2025
Buy
Common Stock
M-Exempt
Taylor Daphne
SVP, CFO
C-Suite Officer 3
Value: $0
Jul 17, 2025
Buy
Restricted Stock Unit
M-Exempt
Taylor Daphne
SVP, CFO
C-Suite Officer 3
Value: $9
Jul 17, 2025
Buy
Restricted Stock Unit
M-Exempt
Niederhuber John
Director
Director 1
Value: $3
Jul 17, 2025
Buy
Common Stock
M-Exempt
Niederhuber John
Director
Director 1
Value: $0
Jul 17, 2025
Buy
Restricted Stock Unit
M-Exempt
Grant Grady Iii
Director
Director 1
Value: $3
Jul 17, 2025
Buy
Common Stock
M-Exempt
Grant Grady Iii
Director
Director 1
Value: $0
Jul 17, 2025
Buy
Restricted Stock Unit
M-Exempt
Abdun-nabi Daniel
Director
Director 1
Value: $3
Jul 17, 2025
Buy
Common Stock
M-Exempt
Abdun-nabi Daniel
Director
Director 1
Value: $0
Jul 17, 2025
Buy
Restricted Stock Unit
M-Exempt
Kunz Barbara Lopez
Director
Director 1
Value: $3
Jul 17, 2025
Buy
Common Stock
M-Exempt
Kunz Barbara Lopez
Director
Director 1
Value: $0
Jul 17, 2025
Buy
Restricted Stock Unit
M-Exempt
Harsanyi Zsolt
Director
Director 1
Value: $3
Jul 17, 2025
Buy
Common Stock
M-Exempt
Harsanyi Zsolt
Director
Director 1
Value: $0
Jul 01, 2025
Buy
Common Stock
Huebner Dirk
SVP, Cmo
Officer 0
Value: $0
Jul 01, 2025
Buy
Common Stock
Huebner Dirk
SVP, Cmo
Officer 0
Value: $0
Mar 04, 2025
Buy
Common Stock
M-Exempt
Taylor Daphne
SVP, CFO
C-Suite Officer 1
Value: $0
Mar 04, 2025
Buy
Restricted Stock Unit
M-Exempt
Taylor Daphne
SVP, CFO
C-Suite Officer 1
Value: $3
Mar 04, 2025
Buy
Restricted Stock Unit
M-Exempt
Taylor Daphne
SVP, CFO
C-Suite Officer 1
Value: $3
Mar 04, 2025
Buy
Common Stock
M-Exempt
Taylor Daphne
SVP, CFO
C-Suite Officer 1
Value: $0
Mar 03, 2025
Buy
Common Stock
M-Exempt
Kwon Soyoung
SVP, GC, Bd & Corp Affairs
Officer 2
Value: $0
Mar 03, 2025
Buy
Restricted Stock Unit
M-Exempt
Kwon Soyoung
SVP, GC, Bd & Corp Affairs
Officer 2
Value: $6
Mar 03, 2025
Buy
Common Stock
M-Exempt
Lamothe Jeffrey G.
EVP, COO
C-Suite Officer 2
Value: $0
Mar 03, 2025
Buy
Restricted Stock Unit
M-Exempt
Lamothe Jeffrey G.
EVP, COO
C-Suite Officer 2
Value: $6
Mar 03, 2025
Buy
Common Stock
M-Exempt
White Marvin L
President And CEO
CEO / President 6
Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT APTEVO THERAPEUTICS INC
Aptevo Therapeutics
Aptevo Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. Its lead clinical candidate is APVO436, a bispecific T-cell engaging antibody candidate that is in Phase 1b clinical trial for acute myelogenous leukemia and myelodysplastic syndrome. The company's preclinical candidates also include ALG.APV-527, an investigational ...
GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
2.22% Jul 27
UNFI
$49.05
3.63% Jul 27
BIIB
$202.19
0.376% Jul 24
TSCO
$30.32
1.48% Jul 23
S
SW
$43.71
5.17% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE